Literature DB >> 28186368

Gastrointestinal involvement in the Ehlers-Danlos syndromes.

Asma Fikree, Gisela Chelimsky, Heidi Collins, Katcha Kovacic, Qasim Aziz.   

Abstract

Current evidence suggests that an association exists between non-inflammatory hereditary disorders of connective tissue such as the Ehlers-Danlos syndromes (EDS) and gastrointestinal (GI) symptoms. Patients with EDS can present with both structural problems such as hiatus hernias, visceroptosis, rectoceles, and rectal prolapse as well as functional problems such as disordered gut motility. It has recently been demonstrated that patients with hypermobile EDS (hEDS) present with GI symptoms related to the fore and hind-gut and these patients frequently meet the criteria for functional gastrointestinal disorders such as functional dyspepsia and irritable bowel syndrome. Presence of GI symptoms in EDS patients influences their quality of life. Specific evidence based management guidelines for the management of GI symptoms in EDS patients do not exist and these patients are often treated symptomatically. There is, however, recognition that certain precautions need to be taken for those patients undergoing surgical treatment. Future studies are required to identify the mechanisms that lead to GI symptoms in patients with EDS and more specific treatment guidelines are required.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ehlers-Danlos syndrome; abdominal pain; constipation; diarrhea; gut motility

Mesh:

Year:  2017        PMID: 28186368     DOI: 10.1002/ajmg.c.31546

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  22 in total

1.  Systemic manifestations of Ehlers-Danlos syndrome.

Authors:  Bo Song; Peter Yeh; John Harrell
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-26

Review 2.  The challenges of chronic pain and fatigue.

Authors:  Jessica A Eccles; Kevin A Davies
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

3.  Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.

Authors:  Weiyi Mu; Michael Muriello; Julia L Clemens; You Wang; Christy H Smith; Phuong T Tran; Peter C Rowe; Clair A Francomano; Antonie D Kline; Joann Bodurtha
Journal:  Am J Med Genet A       Date:  2019-01-31       Impact factor: 2.802

4.  Fragility of Life: Recurrent Intestinal Perforation Due to Vascular Ehlers-Danlos Syndrome.

Authors:  Lindsay A Sceats; Preeti A Sukerkar; Shyam S Raghavan; Alaleh Esmaeili Shandiz; Andrew Shelton; Cindy Kin
Journal:  Dig Dis Sci       Date:  2019-08       Impact factor: 3.199

5.  Obesity surgery and Ehlers-Danlos syndrome: challenges and considerations based on a case report.

Authors:  I N Gerogiannis; I D Gkegkes; N J Dempster; R S Gillies; B Sgromo
Journal:  Ann R Coll Surg Engl       Date:  2019-09-18       Impact factor: 1.891

Review 6.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

7.  Can H2 -receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19-year-old female? A case report.

Authors:  Susan J Allen; Paul L Chazot; C Jane Dixon
Journal:  Br J Clin Pharmacol       Date:  2018-04-18       Impact factor: 4.335

8.  Gastrointestinal symptoms in postural tachycardia syndrome: a systematic review.

Authors:  Shahram E Mehr; Adrian Barbul; Cyndya A Shibao
Journal:  Clin Auton Res       Date:  2018-03-16       Impact factor: 4.435

9.  Colonic Diverticulosis. Is there a Genetic Component?

Authors:  Ana Maria Miulescu
Journal:  Maedica (Bucur)       Date:  2020-03

10.  Gastrointestinal and eating problems in women with Ehlers-Danlos syndromes.

Authors:  Carolina Baeza-Velasco; Sonia Lorente; Elisabet Tasa-Vinyals; Sébastien Guillaume; Maria Soledad Mora; Paola Espinoza
Journal:  Eat Weight Disord       Date:  2021-02-13       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.